Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Beyond peanuts: which legumes trigger childhood allergies?

NCT ID NCT07811141

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 09, 2026 · Last updated Sep 10, 2026 · Updated 1 time

Summary

Researchers at a French hospital are following 100 children aged 6 months to 17 years who are allergic to legumes other than peanut, such as peas, chickpeas, lentils, soy, lupin, and fava beans. The study tracks which legumes cause reactions, how old children are at first symptoms, and how severe those reactions become. Children receive standard allergy care, and families answer quality-of-life questionnaires. A blood sample from each child goes into a biobank to help validate future diagnostic tests.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If the study maps which legumes trigger allergies and how severe reactions get, doctors could diagnose these allergies more accurately and manage them better. Blood samples stored in a biobank may help validate future diagnostic tests.
What could go wrong
This is an observational study, so it will not test a treatment or cure. Findings from 100 children at one hospital may not apply to all children with legume allergies, and the results depend on families staying in the study for up to five years.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 100 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Sep 2026

An estimate. Start dates often move.

Expected to finish

Sep 2034

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Cohort of patients with the disease (leguminous allergy), between 6 months to 17 years old, with medical follow up in Pneumo-allergy unit - CHU Lille

Ages

6 months to 17 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Subjects aged 6 months to 17 years old * Medical diagnosis of allergy to one or more leguminous : * Clinical reaction following real-life exposure AND positive skin and/or biological sensitization * Allergy confirmed by a positive oral food challenge (OFC) in cases of sensitization without a history of clinical reaction * Subjects seen in a pediatric pneumo-allergy unit (consultation or hospitalization) Exclusion Criteria: * Isolated IgE-mediated peanut allergy * Patients aged 18 years or older * Minor patient or legal representant (parental authority) Refusal

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Hypersensitivity, food are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • CHU Lille

    Lille, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.